Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 96.78M | 46.93M | 24.06M | 135.83M | 164.61M |
| Total Depreciation and Amortization | 55.13M | 56.84M | 60.94M | 58.52M | 57.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.76M | 13.36M | 6.90M | 19.32M | -14.81M |
| Change in Net Operating Assets | -104.39M | -126.94M | 79.10M | -91.22M | -29.28M |
| Cash from Operations | 55.28M | -9.81M | 171.00M | 122.45M | 178.38M |
| Capital Expenditure | -25.11M | -36.25M | -49.60M | -75.26M | -59.83M |
| Sale of Property, Plant, and Equipment | 6.77M | 3.77M | 1.72M | 112.30K | 1.26M |
| Cash Acquisitions | 0.00 | -2.33M | -34.45M | -- | -- |
| Divestitures | 0.00 | 52.90K | -- | -- | -- |
| Other Investing Activities | 63.11M | 75.35M | -207.15M | -40.39M | -50.74M |
| Cash from Investing | 44.77M | 40.59M | -289.49M | -115.53M | -109.31M |
| Total Debt Issued | -- | -- | 8.61B | 8.97B | 2.61B |
| Total Debt Repaid | 262.00M | -5.82B | -411.00M | -288.00M | -239.00M |
| Issuance of Common Stock | 68.00M | 248.00M | 79.00M | 30.00M | 92.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -69.72M | -- | 0.00 | 0.00 | -76.27M |
| Other Financing Activities | -1.24B | -1.54B | -1.24B | -936.00M | -1.12B |
| Cash from Financing | -79.19M | -75.30M | 76.94M | 87.30M | -60.97M |
| Foreign Exchange rate Adjustments | -31.40K | 412.60K | 5.61M | 4.02M | 2.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.83M | -44.11M | -35.95M | 98.24M | 10.33M |